RecruitingISRCTN16976551
Development of a guideline for the early detection of psychosis in long-term care facilities
In BelgiumSchizophreniaResearch studyAges 18+
Study directory
Back to overviewSchizophrenia studies
Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
RecruitingISRCTN79060696
gameChange VR: automated virtual therapy to help people with psychosis reduce anxious avoidance of everyday situations
In United KingdomSchizophreniaResearch studyAges 16+
RecruitingISRCTN11089633
Testing the clinical effectiveness of Social Recovery Therapy for people with psychosis and social disability
In United KingdomSchizophreniaResearch studyAges 18–65
RecruitingEUCTR 2021-000350-26
A double blind, randomized, placebo-controlled, adaptive 24-week Phase IIb trial to evaluate the efficacy of vafidemstat in negative symptoms and cognitive impairment associated with schizophrenia....
This study transferred to CTIS. HopeStage uses that newer record for the displayed status. A country's status does not guarantee that an individual site accepts participants.
Multiple locations, including KazanlikSchizophreniaHistorical research record
RecruitingEUCTR 2021-001333-38
Cognitive effects of adjuntive Vortioxetine in early Schizophrenia
This study transferred to CTIS. HopeStage uses that newer record for the displayed status. A country's status does not guarantee that an individual site accepts participants.
In SevillaSchizophreniaHistorical research record
RecruitingNCT07493551
A Bioequivalence Study of PP3M in people with Schizophrenia
In BeijingSchizophreniaMedication studyAges 18–65
RecruitingNCT06821945
A study Safety and Efficacy of Olanzapine Titration Schedule in people with Schizophrenia
In DaeguSchizophreniaMedication studyAges 19+
RecruitingNCT07225712
A Long-term Administration study of SEP-363856 in people with Schizophrenia
What is this study about?
In FukuokaResearchers are studying SEP-363856, tracking side effects to assess long-term safety and tolerability in people with schizophrenia.
SchizophreniaMedication studyAges 18+
RecruitingNCT07459647
A Long-Term Study of ML-007C-MA in Adults With Schizophrenia
What is this study about?
Multiple locations, including Little RockResearchers are studying ML-007C-MA, tracking side effects to assess long-term safety and tolerability in adults with schizophrenia.
SchizophreniaMedication studyAges 18–65
RecruitingNCT07423546
A PET/MRI Study of Cobenfy on Dopamine Transmission in Schizophrenia
In New YorkSchizophreniaMedication studyAges 18–50
RecruitingNCT07410507
Brenipatide in adults with Schizophrenia
What is this study about?
Multiple locations, including Little RockThis study evaluates the safety and effectiveness of Brenipatide for people with schizophrenia.
SchizophreniaMedication studyAges 18–55
RecruitingNCT07145918
Adverse Events, Change for schizophrenia
What is this study about?
Multiple locations, including Little RockThis study evaluates the safety and effectiveness of Emraclidine for people with schizophrenia.
SchizophreniaMedication studyAges 18–65
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.